HYDERABAD:The Hyderabad-based vaccine manufacturer, Bharat Biotech, has been accorded permission by the Drug Controller General of India (DCGI) to initiate Phase I & II human clinical trials for India’s first vaccine candidate against COVID-19.
It was developed and manufactured at the company’s Bio-safety Level-III high containment facility at Genome Valley in the city.
Meanwhile, another big single-day spike of 19,459 COVID-19 cases took India’s tally close to 5.5 lakh on Monday, even as the recovery rate further improved to 58.67 per cent.
India’s COVID-19 case tally rose to 5,48,318, while the death toll climbed to 16,475 with 380 new fatalities, according to the Union Health Ministry data.
This is the sixth consecutive day that coronavirus infections have increased by more than 15,000.